Latest Regenerative Wound News

Cytora Therapeutics Teams Up with Made Scientific and Zeo ScientifiX to Launch Stem Cell Therapy for Diabetic Foot Ulcers in the US

The partnership will focus on bringing oral mucosal stem cell therapy for diabetic foot ulcers to Florida, with FDA trials planned.

FDA clearance of Theracor introduces a new sheet-form umbilical cord device, expanding options for advanced wound care management.

The latest additions aim to support clinicians treating smaller wounds, enhancing flexibility and workflow in surgical wound care.

The new agreement enables Vizient members broader access to BioTissue’s amniotic membrane products for diverse clinical applications.

The company will produce its FDA-approved diabetic foot ulcer product and others at the new facility, creating over 200 full-time jobs.